Adma Biologics

ADMA Biologics develops, manufactures and sells specialty plasma‑derived biologics—including BIVIGAM, ASCENIV, and Nabi‑HB—for immune deficiencies and infectious diseases. Its pipeline and source‑plasma operations position the company for strong growth in a high‑barrier market.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 677
HQ: Ramsey

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
ADMA	Adma Biologics Cap: 4.3B \| P/E: 20.9	EQUITY	NGM	USD	US0008991046	Active	📈